The RCMI Center for Cancer Research established through NIH/NIMHD's RCMI program will continue to be a critical support mechanism in driving Xavier's efforts to enhance and expand its biomedical research capabilities. As stated in Section 1, the primary goal of the RCMI is to enhance faculty and programmatic research competitiveness, especially as related to the areas of cancer, minority health disparities and translational research. The Administrative Core will achieve this goal through the following aims:
Aim 1. To provide effective leadership in governing, monitoring and guiding the key activities of the RCMI program;
Aim 2. To provide user-friendly assistance in developing successful proposals for external support and to patent and license intellectual property;
Aim 3. To engage in strategic planning for ongoing development of the RCMI program and coordinate the effort with the University's strategic planning process.
Aim 4. To promote and facilitate the development of a cohesive group of faculty committed to being actively engaged in health disparities and translational research. The Administrative Core will consist of two Pis: Dr. Gene D'Amour and Dr. Guangdi Wang. Dr. Wang will also serve as the Program Director. In addition, there will be two Associate PDs, a Program Advisor/Consultant, and a Program Manager. The Administrative Core members will meet monthly with the Activity Leaders including the Core Directors and Co-Directors to review progress, identify problems, discuss and implement solutions and improvement plans to ensure that each specific aim is achieved as measured by assessment milestones.

Agency
National Institute of Health (NIH)
Institute
National Institute on Minority Health and Health Disparities (NIMHD)
Type
Research Centers in Minority Institutions Award (G12)
Project #
2G12MD007595-06
Application #
8845382
Study Section
Special Emphasis Panel (ZMD1-MLS (01))
Project Start
Project End
Budget Start
2014-08-01
Budget End
2015-03-31
Support Year
6
Fiscal Year
2014
Total Cost
$1,193,274
Indirect Cost
$272,748
Name
Xavier University of Louisiana
Department
Type
DUNS #
020857876
City
New Orleans
State
LA
Country
United States
Zip Code
70125
Stratford Jr, Robert; Vu, Christopher; Sakon, Joshua et al. (2014) Pharmacokinetics in rats of a long-acting human parathyroid hormone-collagen binding domain peptide construct. J Pharm Sci 103:768-75
Pingali, Subramanya; Donahue, James P; Payton-Stewart, Florastina (2014) Weak C-H···X (X = O, N) hydrogen bonds in the crystal structure of dihydroberberine. Acta Crystallogr C Struct Chem 70:388-91
Zheng, Shilong; Zhong, Qiu; Mottamal, Madhusoodanan et al. (2014) Design, synthesis, and biological evaluation of novel pyridine-bridged analogues of combretastatin-A4 as anticancer agents. J Med Chem 57:3369-81
Dougherty, Casey A; Furgal, Joseph C; van Dongen, Mallory A et al. (2014) Isolation and characterization of precise dye/dendrimer ratios. Chemistry 20:4638-45
Li, Xiao-Lin; Sluijter, Marjolein; Doorduijn, Elien M et al. (2014) Limited density of an antigen presented by RMA-S cells requires B7-1/CD28 signaling to enhance T-cell immunity at the effector phase. PLoS One 9:e108192
Sridhar, Jayalakshmi; Sfondouris, Mary E; Bratton, Melyssa R et al. (2014) Identification of quinones as HER2 inhibitors for the treatment of trastuzumab resistant breast cancer. Bioorg Med Chem Lett 24:126-31
Zheng, Shilong; Zhong, Qiu; Xi, Yulan et al. (2014) Modification and biological evaluation of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion. J Med Chem 57:6653-67
Payton-Stewart, Florastina; Tilghman, Syreeta L; Williams, LaKeisha G et al. (2014) Benzimidazoles diminish ERE transcriptional activity and cell growth in breast cancer cells. Biochem Biophys Res Commun 450:1358-62
Samaan, Nawras; Zhong, Qiu; Fernandez, Jayjoel et al. (2014) Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents. Eur J Med Chem 75:123-31
Ledet, Grace; Pamujula, Sarala; Walker, Valencia et al. (2014) Development and in vitro evaluation of a nanoemulsion for transcutaneous delivery. Drug Dev Ind Pharm 40:370-9

Showing the most recent 10 out of 33 publications